Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform (ELEPHAS-01) (NCT05478538)

🧪 Interventions in This Study

• Core Needle, Forceps, or Punch Biopsy (PROCEDURE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (7 Sites)

• UCLA Medical Center — Los Angeles, California
• James M Stockman Cancer Institute — Frederick, Maryland
• New York Cancer & Blood Specialists — Shirley, New York
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
• Gabrail Cancer Center — Canton, Ohio
• JPS Health Network — Fort Worth, Texas
• Baylor Scott & White Research Institute — Temple, Texas

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in NSCLC (Non-small Cell Lung Cancer)

• A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946 — Fairfax, Virginia
• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) — Birmingham, Alabama

Explore by condition: All NSCLC (Non-small Cell Lung Cancer) clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.